✦ LIBER ✦

Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters

✍ Scribed by Lotte Engell-Noerregaard; Troels Holz Hansen; Mads Hald Andersen; Per thor Straten; Inge Marie Svane

Book ID: 105967487
Publisher: Springer-Verlag
Year: 2008
Tongue: English
Weight: 845 KB
Volume: 58
Category: Article
ISSN: 0340-7004
DOI: 10.1007/s00262-008-0568-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lack of correlation between peripheral b

Lack of correlation between peripheral blood lymphokine-activated killer (lak) cell function and clinical response in patients with advanced malignant melanoma receiving recombinant interleukin 2

✍ A. K. Ghosh; H. Dazzi; N. Thatcher; M. Moore 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 634 KB

A phase-1/11 study of recombinant interleukin 2 (rll-2) was performed in 31 melanoma patients. The first dose of rlL-2 was given intrasplenically followed 4 hr later by an i.v. dose and 3 further i.v. doses on alternate days. Three courses of treatment were planned at 3-week intervals. The maximum t

Wild-type and modified gp100 peptide-pul

Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used

✍ W. Joost Lesterhuis; Gerty Schreibelt; Nicole M. Scharenborg; H. Mary-lène H. Br 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 352 KB

Assessment of immunologic response and r

Assessment of immunologic response and recurrence patterns among patients with clinical recurrence after vaccination with a preventive HER2/neupeptide vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02

✍ Asna Amin; Linda C. Benavides; Jarrod P. Holmes; Jeremy D. Gates; Mark G. Carmic 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 486 KB

Development of an allogeneic whole-cell

Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma

✍ A.N. Alexander; M.K. Huelsmeyer; Ann Mitzey; R.R. Dubielzig; I.D. Kurzman; E.G. 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 312 KB

Response assessment classification in pa

Response assessment classification in patients with advanced renal cell carcinoma treated on clinical trials : Effect of measurement criteria and other parameters

✍ Lawrence H. Schwartz; Madhu Mazumdar; Liang Wang; Alex Smith; Stephanie Marion; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

## Abstract ## BACKGROUND The objective of the current study was to evaluate the effect on response assessment classification in patients with metastatic renal cell carcinoma (RCC) using unidimensional (Response Evaluation Criteria in Solid Tumors) and bidimensional (World Health Organization) cri

Clinical studies on cell-mediated immuni

Clinical studies on cell-mediated immunity in patients with malignant disease I. Effect of immunotherapy with OK-432 on lymphocyte subpopulation and phytomitogen responsiveness in vitro

✍ Atsushi Uchida; Takashi Hoshino 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 713 KB